M.J. is a 65-year-old woman who has been diagnosed with acute myeloid leukemia (AML)

M.J. is a 65-year-old woman who has been diagnosed with acute myeloid leukemia (AML). After undergoing chemotherapy treatment with cytarabine and daunorubicin, she is prepared for an autologous stem cell transplant.

• What are the advantages of an autologous versus an allogenic stem cell transplant?
• What are three complications with s/s that can occur with stem cell infusions?
• What are some prophylactic interventions that can be done for complications?

Two days later M.J. vital signs are T 100.5F, HR 100, RR 28, B/P 90/50. SpO2 94% RA

CBC results:

WBC: 12,000

RBC: 2.9 million/mcl

Hemoglobin: 8.6 g/dL

Hematocrit: 27.2%

MCV: 78

Platelets: 55,000 cells/mcL

*Give two specific complications that are possibly occurring with M.J.